Kraken IPO Date: Why It Paused and What Comes Next

There is no Kraken IPO date yet, and the earliest reported target is the second quarter of 2027. Kraken's parent company, Payward, confidentially submitted a draft S-1 to the SEC in November 2025, froze its plans in March 2026 as crypto markets cooled, and was reported by CoinDesk on 2 September 2026 to be aiming for Q2 2027 at the earliest. Payward has no ticker, no public S-1 and no price range.

Kraken is not listed on OpenStocks as of October 2026. This guide explains where the IPO stands, how Payward has been valued, why it's in no rush, and what would signal that a listing is back on.

As of October 2026: based on Payward's November 2025 announcement, CoinDesk reporting (March, 2 September and 26 September 2026), crypto.news, and reporting on Nasdaq Ventures' September 2026 investment. Dates and valuations can change; verify before acting.

Is Kraken going public?

Yes, eventually, but not in 2026. The sequence so far:

The confidential draft remains on file, but no public S-1 has appeared on EDGAR. Because the draft is confidential, outsiders can't see its contents or how far SEC review has progressed.

Kraken IPO date: what "Q2 2027 at the earliest" means

The Q2 2027 target comes from people familiar with the matter cited by CoinDesk, not from a company announcement. Payward hasn't given a date. Treat it as a floor, not a forecast. To list in Q2 2027, Payward would need to file a public S-1 at least 15 days before a roadshow, set a price range and ticker in an amended filing, and find a market willing to price a crypto exchange at or above its private marks.

The last condition is the hard one. The March pause was driven by falling crypto prices and trading volumes, which hit exchange revenue directly. A recovery in volumes would likely bring the IPO forward; another downturn would push it out again.

Kraken valuation

The small step-up from $20 billion to $21 billion over ten months, during a weak crypto market, tells you two things. Strategic investors still want a stake, and nobody is paying a large premium while volumes are soft. Any IPO price will be benchmarked against these two marks.

What the business looks like

CoinDesk reported Payward's adjusted revenue for the second quarter of 2026 at $508 million, up 17% from a year earlier despite lower transaction volume. Payward has been expanding beyond spot crypto trading into banking-style services, asset management, institutional products and tokenized equities. Its leadership says it can fund that expansion from its own balance sheet, which is why an IPO is optional rather than urgent.

Why Kraken is in no rush

• Profitability. Payward says it is profitable, so it doesn't need public capital to operate.

• Strategic capital is available. Citadel Securities and Nasdaq have both invested; strategic partners bring distribution as well as money.

• Valuation risk. Listing into a soft crypto tape risks pricing below the $20 to $21 billion private marks.

• Product build-out. The Nasdaq partnership targets a Q2 2027 launch of tokenized "Nasdaq Equity Tokens" built on Payward's xStocks infrastructure. Listing once that is live would give public investors a broader story than exchange fees.

Kraken, tokenized stocks and what it means for onchain investors

The Nasdaq tie-up matters beyond Kraken's own IPO. It shows a major exchange operator backing tokenized equity rails, the same broad category as tokenized pre-IPO exposure. If you want to understand how tokenized instruments differ from shares, start with tokenized pre-IPO stocks for beginners and what are tokenized pre-IPO stocks?

The distinction to keep in mind: tokenized listed stocks typically track shares that already trade on an exchange, while tokenized pre-IPO exposure tracks companies with no public price at all. That makes pricing, liquidity and risk very different. OpenStocks sits in the second category, offering BEP-20 tokens on BNB Chain with economic price exposure to Anthropic, Figure AI, Anduril and Neuralink. No ownership, voting, dividends or information rights, and not available to US persons. Why OpenStocks runs on BNB Chain covers the infrastructure choice.

Can you buy Kraken stock before the IPO?

Not on an exchange. Payward shares are privately held. Options are limited to private secondary sales for eligible investors, where available, and depend on company transfer approvals. Kraken is not listed on OpenStocks. Be wary of any token or website claiming to offer "Kraken shares" or a "KRKN" ticker: Payward has published no ticker.

Prediction markets offer another view of the timeline. Venues such as Polymarket list Kraken IPO timing contracts, which are bets on an event, not exposure to the company. We compare event contracts with price-exposure tokens in Kalshi and Polymarket vs OpenStocks.

Signals that the Kraken IPO is back on

1. A public S-1 on EDGAR for Payward, Inc.

2. Sustained recovery in crypto trading volumes, visible in exchange data and Payward's own disclosures.

3. Peer performance. How listed crypto companies trade sets the comparable multiple.

4. The Nasdaq Equity Token launch, targeted for Q2 2027.

5. New senior hires or board changes typical of pre-IPO preparation.

For context on how other 2026 filers are moving, see Anthropic's IPO filing and Discord's IPO status, both of which filed confidentially like Payward. The wider pipeline is covered in pre-IPO companies 2026.

How listed crypto companies set the bar for Kraken

Public investors will price Payward against crypto companies that are already listed. The main reference points:

The 2025 crypto listings came during a strong market. How those stocks have traded since, and how trading volumes recover, will shape the multiple Payward can command. A weak peer group would make it harder to list above the $20 to $21 billion private marks.

Kraken is not alone in waiting. Revolut says it won't list before 2028 (Revolut IPO and share price) and Stripe says an IPO is not a priority (Stripe IPO date).

What a Kraken listing would mean for tokenized stock investors

A listed Payward would be one of the few public companies whose own business includes issuing and trading tokenized equities. That would give investors in tokenized products a public benchmark for how the market values this infrastructure, and Payward's filings would disclose more about volumes, regulation and custody than private companies normally share. For anyone comparing onchain products, those disclosures would be worth reading even without buying the stock.

Key takeaways

• Payward (Kraken's parent) filed a confidential draft S-1 in November 2025; no public S-1 yet.

• The IPO was paused in March 2026; the latest reported target is Q2 2027 at the earliest.

• Private valuation: $20 billion (Nov 2025), $21 billion (Nasdaq Ventures, Sept 2026, reported).

• Q2 2026 adjusted revenue was reported at $508 million, up 17% year on year; Payward says it is profitable.

• Kraken has no ticker and is not listed on OpenStocks.

FAQ

When is the Kraken IPO date?

No date is set. CoinDesk reported in September 2026 that Payward is targeting the second quarter of 2027 at the earliest.

Has Kraken filed for an IPO?

Payward announced a confidential draft S-1 submission in November 2025. No public S-1 has been filed.

What is Kraken's valuation?

$20 billion after its November 2025 raise, and a reported $21 billion in Nasdaq Ventures' September 2026 investment.

What will Kraken's stock ticker be?

Not announced. Any ticker you see quoted now isn't official.

Will non-US investors be able to buy Kraken stock?

After a US listing, yes, through any broker that offers US-listed shares. Before that, there is no public route, and Kraken is not listed on OpenStocks.

Disclaimer

This article is for information only and is not investment advice. Kraken/Payward is not listed on OpenStocks, and OpenStocks is not affiliated with Kraken, Payward, Nasdaq or any company mentioned. OpenStocks tokens represent economic price exposure only, with no ownership, voting, dividends or information rights, and are not available to US persons or persons in the United States. Eligibility depends on your jurisdiction; see the Terms for the full list of prohibited jurisdictions. High risk, including possible total loss.